Continued efficacy of neratinib in patients with HER2-positive early-stage breast cancer: Final overall survival analysis from the randomized phase 3 ExteNET trial

Authors
Publication date
1 January 2021
Publisher
Amer Assoc Cancer Research

Abstract

WOS:000618737700193[No Abstract Available

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Ege University Institutional Repository

    redirect
    oaioai:gcris.ege.edu.tr:11454/696...
    Last time updated on 23/11/2023